WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan
SHANGHAI, Nov. 30, 2022 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services for the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, announced that it is a recipient of the 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award...
First Patient dosed in a Head-to-Head First-Line Bridging Study of HANSIZHUANG for ES-SCLC treatment in the US
SHANGHAI, Nov. 30, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first patient was dosed in NCT05468489, a bridging head-to-head trial in the United States comparing HANSIZHUANG (serplulimab), an innovative anti-PD-1 monoclonal antibody (mAb) independently developed by the company to standard of care Atezolizumab (anti-PD-L1 mAb). Based on the positive feedback of FDA Biologics license Application (BLA)...
Infinitus co-organizes the 2022 Responsibilities for Health Forum
The firm releases the National TCM Health Index Report 2022 at the forum GUANGZHOU, China, Nov. 30, 2022 /PRNewswire/ -- Organized by the Office of the National Brands Project of Xinhua News Agency, co-organized by Infinitus with the support of the China Association of Chinese Medicine (CACM), the 2022 Responsibilities for Health Forum (RHF) was held online during the...
Digital Technologies Driving Transformational Growth Across the Biomanufacturing Value Chain
Digitalization enables a sustainable, effective, cost-efficient, and error-free system for biomanufacturing SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- The biomanufacturing sector is experiencing a digitalization transformation that is aligned with Industry 4.0. According to Frost & Sullivan's recent analysis on the digital biomanufacturing industry, digital tools applied across processes, monitoring, analytics, and operations have accelerated biomanufacturing with a data-driven...
United Imaging Selected to Academy of Radiology & Biomedical Imaging Research’s Council of Distinguished Investigators’ Class of 2022
United Imaging's Chief Technology Officer recognized at a ceremony and reception during RSNA on Tuesday, November 29, 2022. HOUSTON, Nov. 29, 2022 /PRNewswire/ -- United Imaging, a global leader in producing advanced medical imaging and radiotherapy equipment, is welcomed today to the Distinguished Investigators' Class, which recognizes outstanding contributions to the field of medical imaging. According to the...
COSMAX Group Expands Business to Pet Care…Targeting $200B Market
Started operations of pet supplements manufacturing plant Produces 'human-grade' products with differentiated ingredients Plans to expand pet care business from supplements to cosmetics SEONGNAM, South Korea, Nov. 29, 2022 /PRNewswire/ -- COSMAX Group, the leader in the global cosmetics ODM (Original Development Manufacturing) market, is expanding its business area to pet care. Starting the operation of its...
Mintal Tracker Wins Highest Honor From Prestigious 2022 Fall Digital Health Awards
The award-winning app uses AI to monitor and help users achieve healthier sleep SUNNYVALE, Calif., Nov. 29, 2022 /PRNewswire/ -- Mintal Tracker, a sleep tracking app driven by artificial intelligence (AI) technology that offers a scientific approach to healthier sleep, received a 2022 Gold Award in the Mobile Application category of the Fall session of the 24th annual...
Etiometry Applauded by Frost & Sullivan for Enabling Timely Decision Support for Critical Care with Its Digital and Automated Solution
The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, Nov. 29, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the US clinical decision support for the critical care industry and, based on its findings, recognizes Etiometry with the 2022 US Clinical Decision Support market...
A bispecific antibody molecule jointly developed by Buchang Pharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, received IND clearance from NMPA for clinical trial
NANJING, China, Nov. 29, 2022 /PRNewswire/ -- Buchang Biopharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, recently received IND approval of BC008-1A from China NMPA for Phase 1 clinical trial. BC008-1A (NMPAIND number: CXSL2200315), a bispecific antibody drug co-targeting the immune checkpoints PD-1 and TIGIT, for treatment of patients with advanced solid tumors....
TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany
PARIS, Nov. 29, 2022 /PRNewswire/ -- TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® Satylia® in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from January 2023. SymbioLife® Satylia® is a precision probiotic with a characterized mechanism of...
